These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 55529)

  • 21. Cellular immune modulation after a single high dose of Levamisole in patients with carcinoma.
    Lewinski UH; Mavligit GM; Hersh EM
    Cancer; 1980 Nov; 46(10):2185-94. PubMed ID: 7427861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levamisole in the treatment of Hodgkin's disease.
    Berényi E; Kávai M; Szabolcsi M; Szegedi G
    Acta Med Acad Sci Hung; 1979; 36(2):177-85. PubMed ID: 317549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular immune reactivity in patients with rheumatoid arthritis and effects of levamisole.
    Basch CM; Spitler LE; Engleman EG; Engleman EP
    J Rheumatol; 1977; 4(4):377-88. PubMed ID: 604477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer. I. A three-year clinical follow up.
    Padmanabhan TK; Balaram P; Vasudevan DM
    Neoplasma; 1987; 34(5):627-32. PubMed ID: 3696303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
    Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
    J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of levamisole hydrochloride on advanced and recurrent breast cancer--LMS randomized controlled study of a group responding to CAF (cyclophosphamide, adriamycin, and 5-FU) therapy].
    Taguchi T; Izuo M; Ogawa N; Hayasaka H; Akai S; Tazima S; Fujii G; Tominaga T; Okamoto T; Kubo K; Yoshida M; Ota K; Sakai K; Hattori T; Inoue G; Nomura Y
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1595-608. PubMed ID: 6764119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter: Levamisole in the treatment of cancer.
    Ward HW
    Lancet; 1976 Mar; 1(7959):594-5. PubMed ID: 55877
    [No Abstract]   [Full Text] [Related]  

  • 28. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
    Cafiero F; Gipponi M; Lionetto R;
    J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levamisole treatment in ulcus cruris. A double-blind placebo-controlled study.
    Morias J; Peremans W; Campaert H; Mertens RL
    Arzneimittelforschung; 1979; 29(7):1050-2. PubMed ID: 387047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double blind randomized prospective trial of levamisole/placebo in stage I cutaneous malignant melanoma.
    Loutfi A; Shakr A; Jerry M; Hanley J; Shibata HR
    Clin Invest Med; 1987 Jul; 10(4):325-8. PubMed ID: 3308241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of levamisole as a surgical adjuvant therapy for malignant melanoma.
    Gonzalez RL; Spitler LE; Sagebiel RW
    Cancer Treat Rep; 1978 Nov; 62(11):1703-7. PubMed ID: 365324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Controlled trial of levamisole in rheumatoid arthritis. Clinical and immunological study of 22 cases (author's transl)].
    Rondier J; Cayla J; Tron F; Roger M; Bach JF
    Nouv Presse Med; 1978 Oct; 7(34):3023-7, 3029-30. PubMed ID: 364409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter: Levamisole and the immune response.
    N Engl J Med; 1973 Nov; 289(21):1148-9. PubMed ID: 4585358
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognosis of primarily treated localized laryngeal carcinoma ameliorated through levamisole treatment: a randomized pilot study.
    Mussche RA; Kluyskens P
    Oncology; 1980; 37(5):329-35. PubMed ID: 7003457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary report of the use of levamisole in the treatment of bladder cancer.
    Smith RB; deKernion J; Lincoln B; Skinner DG; Kaufman JJ
    Cancer Treat Rep; 1978 Nov; 62(11):1709-14. PubMed ID: 365325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levamisole, B.C.G. and warfarin as adjuvants to chemotherapy for increased survival in advanced breast cancer.
    D'Souza DP; Daly L; Thornes RD
    Ir Med J; 1978 Dec; 71(18):605-8. PubMed ID: 721416
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunotherapy of cancer using levamisole, immunologic control of the post-surgical patient and graphic follow-up].
    de Carli HO; Llargues JM
    Rev Esp Oncol; 1980; 27(1):67-80. PubMed ID: 7209109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.
    Quirt IC; Shelley WE; Pater JL; Bodurtha AJ; McCulloch PB; McPherson TA; Paterson AH; Prentice R; Silver HK; Willan AR
    J Clin Oncol; 1991 May; 9(5):729-35. PubMed ID: 2016615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility and low toxicity of early radiotherapy after high-dose chemotherapy and autologous stem cell transplantation for patients with high-risk stage II-III and locally advanced breast carcinoma.
    Stemmer SM; Pfeffer MR; Rizel S; Hardan I; Goffman J; Gezin A; Neumann A; Kitsios P; Alezra D; Brenner HJ
    Cancer; 2001 Jun; 91(11):1983-91. PubMed ID: 11391576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic human brucellosis and anti-anergic treatment with levamisole.
    Thornes RD
    Vet Rec; 1977 Jul; 101(2):27-30. PubMed ID: 906216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.